Luis Mauricio Trambaioli da Rocha e Lima

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Farmácia

Departamento:

Departamento de Fármacos e Medicamentos

ORCID:

https://orcid.org/0000-0001-6020-0504


Formação:
  • Universidade de Guarulhos

    Nutrição | Graduação | 2018 - 2021
  • Instituto de Física de São Carlos

    | Pós-Doutorado | 2005 - 2006
  • Universidade Federal do Rio de Janeiro

    Química Biológica | Doutorado | 1997 - 2001
  • Universidade Federal do Rio de Janeiro

    Química Biológica | Mestrado | 1996 - 1997
  • Universidade Federal do Rio de Janeiro

    Farmacia | Graduação | 1991 - 1994
Laboratórios:
Nuvens de Palavras:
Artigos:

(93.40% artigos com DOI)

Titulo DOI Ano
Oral delivery of the amylin receptor agonist pramlintide 10.1002/pep2.24346 2024
Spatially resolved distribution of pancreatic hormones proteoforms by MALDI-imaging mass spectrometry 10.1016/j.ab.2024.115570 2024
Mutations in asparaginase II from E. coli and implications for inactivation and PEGylation 10.1016/j.bpc.2023.107041 2023
Brazilian Medicinal Plants with Antiamyloidogenic Activity 10.1007/s43450-023-00424-4 2023
Zinc deficiency disrupts pain signaling promoting nociceptive but not inflammatory pain in mice 10.1590/0001-3765202320220914 2023
Dietary phytate induces subclinical mechanical allodynia in mice 10.1590/1414-431x2023e12955 2023
Modified Asparaginase For Treatment Of CancerHistorical appraisal and future perspectives 10.2174/2452271606666230104143806 2023
Linking B-factor and temperature-induced conformational transition 10.1016/j.bpc.2023.107027 2023
Nutrient-sensing amyloid metastasis 10.1002/biof.1825 2022
The reproducible normality of the crystallographic B-factor 10.1016/j.ab.2022.114594 2022
Formation of subvisible particles in commercial insulin formulations 10.1016/j.colsurfb.2022.112566 2022
Biophysical characterization of two commercially available preparations of the drug containing Escherichia coli L-Asparaginase 2 10.1016/j.bpc.2021.106554 2021
Polymeric microparticle systems for modified release of glucagon-like-peptide-1 receptor agonists 10.1080/02652048.2021.1889059 2021
Amyloidogenicity of peptides targeting diabetes and obesity 10.1016/j.colsurfb.2021.112157 2021
Unambiguous characterization of PEGylation site on human amylin by two-dimensional nuclear magnetic resonance spectroscopy 10.1002/pep2.24252 2021
Dietary zinc restriction promotes degeneration of the endocrine pancreas in mice 10.1016/j.bbadis.2020.165675 2020
Physicochemical and structural properties of lunasin revealed by spectroscopic, chromatographic and molecular dynamics approaches 10.1016/j.bbapap.2020.140440 2020
Amyloidogenesis of feline amylin and plasma levels in cats with diabetes mellitus or pancreatitis 10.1016/j.domaniend.2020.106532 2020
Vancomycin-loaded nanoparticles against vancomycin intermediate and methicillin resistant Staphylococcus aureus strains 10.1088/1361-6528/ab97d7 2020
BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats 10.1016/j.peptides.2019.04.004 2019
Insulin resistance underlying type 2 diabetes 10.1016/S2213-8587(19)30147-0 2019
Physico-chemical stability of co-formulation of PEGylated human amylin with insulin 10.1080/10837450.2019.1621896 2019
Sustained release and pharmacologic evaluation of human glucagon-like peptide-1 and liraglutide from polymeric microparticles 10.1080/02652048.2019.1677795 2019
Heterotropic Modulation of Amylin Fibrillation by Small Molecules: Implications for Formulative Designs 10.1007/s10930-019-09877-w 2019
The toxic nature of murine amylin and the immune responsivity of pancreatic islet to conformational antibody in mice 10.1007/s11010-018-3288-x 2018
Physico-chemical properties of co-formulated fast-acting insulin with pramlintide 10.1016/j.ijpharm.2018.06.039 2018
BZ043, a Novel Amylin Analog, in a Fixed Combination with Insulin Glargine-Nonclinical Results 10.2337/db18-76-OR 2018
Biologically produced silver chloride nanoparticles from B. megaterium modulate interleukin secretion by human adipose stem cell spheroids 10.1007/s10616-018-0257-x 2018
Monitoring asparaginase activity 10.1016/s1470-2045(18)30656-9 2018
Oligomeric transition and dynamics of RNA binding by the HuR RRM1 domain in solution 10.1007/s10858-018-0217-y 2018
Prediabetes definitions and clinical outcomes 10.1016/S2213-8587(17)30011-6 2017
Re: Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions 2017
Subclinical Diabetes 10.1590/0001-3765201720160394 2017
End Functionalization by Ring Opening Polymerization: Influence of Reaction Conditions on the Synthesis of End Functionalized Poly(lactic Acid) 10.21577/0103-5053.20170118 2017
Publish and perish in the hands of predatory journals 10.1590/0001-37652017892 2017
Comprehensive structural analysis of designed incomplete polypeptide chains of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus 10.1371/journal.pone.0182132 2017
Macromolecular confinement of therapeutic protein in polymeric particles for controlled release: insulin as a case study 10.1590/s2175-97902017000216039 2017
Polymorphic distribution of proteins in solution by mass spectrometry: The analysis of insulin analogues 10.1016/j.biologicals.2016.09.011 2017
Pharmacopeia and ANVISA: A Necessary Symbiosis 10.30968/rbfhss.2017.084.001 2017
Yeast-derived biosynthesis of silver/silver chloride nanoparticles and their antiproliferative activity against bacteria 10.1039/c5ra22727e 2016
Refolding, purification, and preliminary structural characterization of the DNA-binding domain of the quorum sensing receptor RhlR from Pseudomonas aeruginosa 10.1016/j.pep.2016.01.006 2016
Regulation of the assembly and amyloid aggregation of murine amylin by zinc 10.1016/j.bpc.2016.09.008 2016
Green production of microalgae-based silver chloride nanoparticles with antimicrobial activity against pathogenic bacteria 10.1016/j.enzmictec.2016.10.018 2016
Amyloidogenesis of the amylin analogue pramlintide 10.1016/j.bpc.2016.09.007 2016
Assignment of polymorphic species of insulin analogues in ion mobility mass spectroscopy 10.1016/j.dib.2016.12.020 2016
Allosteric regulation of the Plasmodium falciparum cysteine protease falcipain-2 by heme 10.1016/j.abb.2015.03.007 2015
Molecular confinement of human amylin in lipidic nanoparticles 2015
Monoconjugation of Human Amylin with Methylpolyethyleneglycol 10.1371/journal.pone.0138803 2015
Effect of tamoxifen in RAFT miniemulsion polymerization during the synthesis of polymeric nanoparticles 10.4322/polimeros.2014.050 2014
Synthesis of Nanoparticles Loaded with Tamoxifen by Miniemulsion RAFT Polymerization 10.1002/masy.201400025 2014
Structural insights into the stabilization of the human immunodeficiency virus type 1 capsid protein by the cyclophilin-binding domain and implications on the virus cycle 10.1016/j.bbapap.2014.12.008 2014
Amylin induces hypoglycemia in mice 2013
A T3R3 hexamer of the human insulin variant B28Asp 10.1016/j.bpc.2013.01.003 2013
Assembly Stoichiometry of bacterial Selenocysteine Synthase and SelC (tRNAsec) 10.1016/j.febslet.2013.02.014 2013
Inhibition of Human Transthyretin Aggregation by Non-Steroidal Anti-Inflammatory Compounds: A Structural and Thermodynamic Analysis 10.3390/ijms14035284 2013
Falcipain-2 inhibition by suramin and suramin analogues 10.1016/j.bmc.2013.04.047 2013
Structural meta-analysis of regular human insulin in pharmaceutical formulations 10.1016/j.ejpb.2013.05.005 2013
Preparation and Characterization of PEGylated Amylin 10.1208/s12249-013-9987-4 2013
Amylin Conjugation with Methoxyl Polyethyleneglycol 10.2174/09298665113209990067 2013
Stepwise oligomerization of murine amylin and assembly of amyloid fibrils 10.1016/j.bpc.2013.07.013 2013
Conformational dissection of Thermomyces lanuginosus lipase in solution 10.1016/j.bpc.2013.12.001 2013
A fluorescence-based assay for octreotide in the kinetic release from depot formulations 2012
Polymeric particles for the controlled release of human amylin 10.1016/j.colsurfb.2012.01.021 2012
Allosteric activation of human ¿-thrombin through exosite 2 by suramin analogs 10.1016/j.abb.2012.02.001 2012
Evaluation of the Antioxidant and Phototoxic Potentials of Bauhinia microstachya var. massambabensis Vaz Leaf Extracts 2012
Allosteric function and dysfunction of the prion protein 10.1007/s00018-011-0847-7 2012
Flavonoid interactions with human transthyretin: Combined structural and thermodynamic analysis 10.1016/j.jsb.2012.07.008 2012
2,4-Dinitrophenol reduces the reactivity of Lys553 in the lower 50-kDa region of myosin subfragment 1 10.1016/j.abb.2010.09.022 2011
The binding of synthetic triiodo l-thyronine analogs to human transthyretin: Molecular basis of cooperative and non-cooperative ligand recognition 10.1016/j.jsb.2010.10.003 2011
Chemical stability study of vitamins thiamine, riboflavin, pyridoxine and ascorbic acid in parenteral nutrition for neonatal use 10.1186/1475-2891-10-47 2011
Structure and Behavior of Human ¿-Thrombin upon Ligand Recognition: Thermodynamic and Molecular Dynamics Studies 10.1371/journal.pone.0024735 2011
On the Denaturation Mechanisms of the Ligand Binding Domain of Thyroid Hormone Receptors 10.1021/jp911554p 2010
Recognition by thyroid hormone receptor of canonical DNA response elements 10.1021/bi901282s 2010
Identification of a novel ligand binding motif in the transthyretin channel 10.1016/j.bmc.2009.11.025 2010
Magnetic field sensor based on a maghemite/polyaniline hybrid material 10.1007/s10853-010-4321-y 2010
Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: Implications to tetramer stability and ligand-binding 10.1016/j.jsb.2010.03.002 2010
Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol binding protein recognition 10.1074/jbc.M110.157206 2010
Response to Radulescu and Brenig: Infectious nucleic acids in prion disease: halfway there 10.1016/j.tibs.2008.10.001 2009
Enhanced prion protein stability coupled to DNA recognition and milieu acidification 10.1016/j.bpc.2008.12.011 2009
Structural and thermodynamic analysis of thrombin:suramin interaction in solution and crystal phases 10.1016/j.bbapap.2009.03.011 2009
Cognate DNA Stabilizes the Tumor Suppressor p53 and Prevents Misfolding and Aggregation 10.1021/bi9003028 2009
Reciprocal remodeling upon binding of the prion protein to its signaling partner hop/STI1 10.1096/fj.09-138974 2009
Ligand Binding and Hydration in Protein Misfolding: Insights from Studies of Prion and p53 Tumor Suppressor Proteins 10.1021/ar900179t 2009
Functionality of phosphorylated vicilin exposed to chemical and physical agents. 10.1016/j.foodchem.2007.09.077 2008
The intriguing nucleic-acid binding properties of the prion protein. 10.1016/j.tibs.2007.11.003 2008
Characterization of the papillomavirus α1E2 peptide unfolded to folded transition upon DNA binding 10.1016/j.febslet.2008.09.041 2008
Low-resolution structure and fluorescence anisotropy analysis of protein tyrosine phosphatase η catalytuc domain 10.1529/biophysj.106.094961 2007
Specificity in DNA recognition by a peptide from E2 protein of papillomavirus 10.1016/j.febslet.2006.02.047 2006
Tetramerization of the LexA repressor in solution. Implications for gene regulation of the E. coli SOS system at acidic pH. 10.1016/j.jmb.2006.03.069 2006
Structural insights into the interaction between prion protein and nucleic acid 10.1021/bi060532d 2006
The amino terminal PrP domain is crucial to modulate prion misfolding and aggregation 10.1529/biophysj.105.067603 2005
Highlights of the 3rd International Conference on High Pressure Bioscience and Biotechnology 10.1590/S0100-879X2005000800001 2005
New insights into conformational and functional stability of human alpha-thrombin probed by high hydrostatic pressure 10.1111/j.0014-2956.2004.04295.x 2004
Hydration and packing effects on prion folding and b-sheet conversion: Pressure spectroscopy and pressure calorimetry studies 2004
Reversible aggregation plays a crucial role on the folding landscape of p53 core domain 10.1529/biophysj.104.044685 2004
Desenvolvimento e estabilidade de suspensões de sulfasalazina em xarope 2004
Positive contribution of hydration on DNA binding by E2 protein from papillomavirus 10.1074/jbc.M407696200 2004
Role of hydration in the closed-to-open transition involved in Ca binding by troponin C 10.1021/bi027102h 2003
Modulation of Prion Protein Oligomerization, Aggregation, and  -sheet Conversion by 4,4'-Dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS) 10.1074/jbc.M312262200 2003
Pressure induces folding intermediates that are crucial for protein-DNA recognition and virus assembly (Review) 10.1016/S0167-4838(01)00348-X 2002
p-Nitrophenylphosphatase activity catalyzed by plasma membrane (Ca(2+) + Mg(2+)ATPase: correlation with structural changes modulated by glycerol and Ca(2+). 10.1023/A:1010477916631 2001
Isolation and Chemical Analysis of a Fatty Acid Fraction of Kalanchoe pinnata with a Potent Lymphocyte Suppressive Activity 10.1055/s-2000-11131 2000
DNA tightens the dimeric DNA-binding domain of human papillomavirus E2 protein without changes in volume 10.1073/pnas.250352197 2000
Distinctive cognate sequence discrimination, bound DNA conformation, and binding modes in the E2 C-terminal domains from prototype human and bovine papillomaviruses. 10.1021/bi001694r 2000
Folding of a dimeric ?-barrel: Residual structure in the urea denatured state of the human papillomavirus E2 DNA binding domain 10.1110/ps.9.4.799 2000
Conformational Changes and Stabilization Induced by Ligand Binding in the DNA-binding Domain of the E2 Protein from Human Papillomavirus 10.1074/jbc.272.31.19295 1997
Eventos:
Nenhum evento cadastrado
Publicações:
Minha Rede: